Comparator: MK0594 5 mg/day
0594-020
Phase 2 small_molecule terminated
Quick answer
Comparator: MK0594 5 mg/day for Alcohol Dependence is a Phase 2 program (small_molecule) at VYNE Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- VYNE Therapeutics
- Indication
- Alcohol Dependence
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- terminated